Related Experiment Video

Updated: Jul 16, 2026

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
11:31

High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model

Published on: August 16, 2019

Targeting MDA5-Mediated Interferon Responses in Type 1 Diabetes: Structural Insights, Mechanism, and Potential

Opeoluwa F Iwaloye1,2, Clayton E Mathews1,2, Danmeng Li2

  • 1Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, Florida, USA.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|July 15, 2026
PubMed

Insights

Melanoma differentiation-associated protein 5 (MDA5) senses viral dsRNA. Its structure dictates immune responses, with variants linked to autoimmunity and viral infections, offering therapeutic targets.

Area of Science:

  • Immunology
  • Structural Biology
  • Molecular Biology

Background:

  • Melanoma differentiation-associated protein 5 (MDA5), encoded by IFIH1, is a key cytosolic sensor for double-stranded RNA (dsRNA).
  • Mutations in IFIH1 lead to MDA5 deficiency, causing immune dysfunction and increased susceptibility to respiratory viral infections.
  • IFIH1 gene variants are associated with autoimmune diseases like type 1 diabetes.

Purpose of the Study:

  • To elucidate the structure-function relationship of MDA5 in dsRNA recognition and type 1 interferon (T1-IFN) signaling.
  • To understand how MDA5 architecture governs innate immune responses to viral dsRNA.
  • To explore the implications of IFIH1 variants in autoimmunity and viral immunity.

Main Methods:

  • Integration of structural biology and signaling principles.
  • Analysis of MDA5 interactions with dsRNA and its role in filament formation.
  • Investigation of downstream signaling pathways including TBK1/IKKε-IRF and NF-κB activation.

Main Results:

  • MDA5 binds dsRNA via its helicase core and C-terminal domain, utilizing ATP-dependent conformational changes to form filaments.
  • Filament assembly exposes N-terminal CARDs, initiating MAVS polymerization and subsequent activation of T1-IFN and inflammatory gene expression.
  • Risk-associated IFIH1 alleles may elevate T1-IFN production thresholds, while loss-of-function variants reduce T1-IFN output and offer protection.

Conclusions:

  • MDA5 structure is critical for sensing viral dsRNA and orchestrating innate immune signaling.
  • IFIH1 variants influence T1-IFN responses, impacting susceptibility to viral infections and autoimmunity.
  • Therapeutic strategies targeting downstream pathways could modulate T1-IFN signaling to manage autoimmunity and preserve antiviral defense.
Keywords:
IFIH1MDA5autoimmunitydsRNA responsetype 1 interferon

More Related Videos

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...